Table 3. Hematotoxicity according to common toxicity criteria (version 4.0) in all patients prior to and after 3 cycles of RLT.
Baseline | After 3 cycles of RLT | |||||||
---|---|---|---|---|---|---|---|---|
CTC 0° (%) | CTC 1° (%) | CTC 2° (%) | CTC 3° (%) | CTC 0° (%) | CTC 1° (%) | CTC 2° (%) | CTC 3° (%) | |
WBC | 43 (87.8) | 4 (8.2) | 1 (2.0) | 1 (2.0) | 42 (85.7) | 5 (10.2) | 2 (4.1) | 0 (0) |
Hb | 7 (14.3) | 33 (67.3) | 7 (14.3) | 2 (4.1) | 30 (61.2) | 03 (6.1) | 12 (24.5) | 4 (8.2) |
Plt | 41 (83.7) | 07 (14.3) | 01 (2.0) | 0 (0) | 37 (75.5) | 07 (14.3) | 2 (4.1) | 3 (6.1)* |
There were no treatment-associated grade 4 or 5 toxicities.
Abbreviations: WBC: white blood cells, Hb: hemoglobin, Plt: platelets
* Two patients with grade 3 thrombocytopenia showed no anemia and one had grade 3 anemia